描述:PHCCC has been shown to act as a group I metabotropic glutamate receptor antagonist with an IC50 of approximately 3 µM. This activity is 67 times more potent than (S)-4-carboxyphenylglycine . This compound has also demonstrated positive allosteric modulation for mGluR-4a, potentiates L-AP4-mediated inhibition of striatopallidal synaptic transmission in vitro, and displays anti-Parkinsonian effects in rat models.
应用:A group I metabotropic glutamate receptor antagonist